Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine
Authors:
- 1 October 2007
- journal article
- research article
- Published by Springer Nature in Science China Life Sciences
- Vol. 50 (5) , 600-604
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V AntigensInfection and Immunity, 2005
- Design and Testing for a Nontagged F1‐V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic PlagueBiotechnology Progress, 2005
- Vaccination against bubonic and pneumonic plagueVaccine, 2001
- An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse modelClinical and Experimental Immunology, 1999
- Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineVaccine, 1998
- A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plagueVaccine, 1997
- Yersinia pestis--etiologic agent of plagueClinical Microbiology Reviews, 1997
- Local and systemic immune response to a microencapsulated sub-unit vaccine for plagueVaccine, 1996
- A new improved sub-unit vaccine for plague: the basis of protectionFEMS Immunology & Medical Microbiology, 1995
- A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine modelVaccine, 1995